NOTICE OF GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 30, 2023 PROXY FORM (CLICK TO VIEW AND DOWNLOAD) ANNUAL REPORT AND CONSOLIDATED …
Watch the KOL Event Replay
Check out the playback of Akari’s virtual KOL event, PAS Nomacopan Potential in Geographic Atrophy (GA), featuring Elias Reichel, M.D., Tufts University School …
Akari Therapeutics to Participate in A.G.P.’s Virtual Healthcare Conference
NEW YORK and LONDON, May 16, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies …
[Read more...] about Akari Therapeutics to Participate in A.G.P.’s Virtual Healthcare Conference
Akari Therapeutics Reports Full-Year 2022 Financial Results and Highlights
NEW YORK and LONDON, May 01, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies …
[Read more...] about Akari Therapeutics Reports Full-Year 2022 Financial Results and Highlights
Akari Therapeutics Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
NEW YORK and LONDON, April 25, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies …
